Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates

Journal of Clinical Microbiology

Volumn 35, Issue 8, 1997, Pages 2031-2039

  Steffan, Paul ^a   Vazquez, Jose A ^a,b,c   Boikov, Dina ^a   Xu, Chun ^a   Sobel, Jack D ^a   Akins, Robert A ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Vet Administration Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DIAGNOSTIC VALUE; DNA FINGERPRINTING; DRUG CHOICE; DRUG POTENCY; FUNGUS CULTURE; FUNGUS IDENTIFICATION; NONHUMAN; PRIORITY JOURNAL; TREATMENT PLANNING;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0030809237     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.8.2031-2039.1997     Document Type: Article

References (64)

1. Banerjee, S. N., T. G. Emori, D. H. Culver, G. P. Gaynes, W. R. Jarvis, and T. Huran. 1991. Secular trends in nusocomial primary bloodstream infections in the United States. Am. J. Med. 91(Suppl. 3b):86S-S9S.
2. Baumgartner, C., A. Freydiere, and Y. Gille. 1996. Direct identification and recognition of yeast species from clinical material by using Albicans ID and CHROMagar Candida plates. J. Clin. Microbiol. 34:454-456.
3. Berenguer, J., T. M. Diaz-Guerra, B. Ruiz-Diaz, J. C. L. B. de Quiros, J. L. Rodriguez-Tudela, and J. V. Martinez-Suarez. 1996. Genetic dissimilarity of two fluconazole resistant Candida albicans strains causing meningitis and oral candidiasis in the same AIDS patient. J. Clin. Microbiol. 34:1542-1545.
4. Berrouane, Y. F., R. J. Hollis, and M. A. Pfaller. 1996. Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J. Clin. Microbiol. 34:1856-1858.
5. Bodey, G. P. 1986. Candidiasis in cancer patients. Am. J. Med. 77S:13-19.
6. Bodey, G. P. 1993. Candidiasis: pathogenesis, diagnosis, and treatment, 2nd ed. Raven Press, Ltd., New York, N.Y.
7. Bostock, A., M. N. Khattak, R. Matthews, and J. Burnie. 1993. Comparison of PCR fingerprinting, by random amplification of polymorphic DNA, with other molecular typing methods for Candida albicans. J. Gen. Microbiol. 139:2179-2184.
8. Carlotti, A., R. Grillot, A. Couble, and J. Villard. 1994. Typing of C. krusei clinical isolates by restriction endonuclease analysis and hybridization with CkF1,2 DNA probe. J. Clin. Microbiol. 32:1691-1699.
9. de Repentigny, L., and E. Reiss. 1984. Current trends in immunodiagnosis of candidiasis and aspergillosis. Rev. Infect. Dis. 6:301-312.
10. Dick, J. D., B. R. Rosengard, W. G. Merz, R. K. Stuart, G. M. Hutchins, and R. Saral. 1985. Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii. Ann. Intern. Med. 102:67-68.
11. El-Zaatari, M., L. Pasarell, M. R. McGinnis, J. Buckner, G. A. Land, and I. F. Salkin. 1990. Evaluation of the updated Vitek yeast identification data base. J. Clin. Microbiol. 28:1938-1941.
12. Engleberg, N. C., and B. I. Eisenstein. 1992. Detection of microbial nucleic acids for diagnostic purposes. Annu. Rev. Med. 43:147-155.
13. Fenn, J., H. Segal, B. Barland, D. Denton, J. Whisenant, H. Chun, K. Christofferson, L. Hamilton, and K. Carroll. 1994. Comparison of updated Vitek yeast biochemical card and API 20C yeast identification systems. J. Clin. Microbiol. 32:1184-1187.
14. Freydiere, A. 1996. Evaluation of CHROMagar Candida plates. J. Clin. Microbiol. 34:2048.
15. Fricker-Hidalgo, H., O. Vandapel, M. A. Duchesne, M. A. Mazoyer, D. Monget, B. Lardy, B. Ledeau, J. Freney, P. Ambroise-Thomas, and R. Grillot. 1996. Comparison of the new API Candida system to the ID 32C system for identification of clinically important species. J. Clin. Microbiol. 34:1846-1848.
16. Garcia, C., B. L. Johnston, G. Corvi, L. J. Walker, and W. L. George. 1987. Intravenous catheter associated Malassezia furfur fungemia. Am. J. Med. 83:790-792.
17. Hazen, K. C. 1995. New and emerging yeast pathogens. Clin. Microbiol. Rev. 8:462-478.
18. Hopfer, R., V. Fainstein, M. Luna, and G. P. Bodey. 1981. Disseminated candidiasis caused by four different Candida species. Arch. Pathol. Lab. Med. 105:454-455.
19. Jandrlic, M., S. Kalenic, D. Labar, J. Jakac-Razumovic, M. Mrsic, V. Plecko, and V. Bogdanic. 1995. An autopsy study of systemic fungal infections in patients with hematologic malignancies. Eur. J. Microbiol. Infect. Dis. 14: 768-774.
20. Jones, J. M. 1990. Laboratory diagnosis of invasive candidiasis. Clin. Microbiol. Rev. 3:32-45.
21. Karyotakis, N., M. Dignani, and E. Anaissie. 1995. SCH 51048, a new antifungal triazole active against hematogenous Candida krusei infections in neutropenic mice. Antimicrob. Agents Chemother. 39:775-777.
22. King, D., J. Rhine-Chalberg, M. A. Pfaller, S. A. Moser, and W. G. Merz. 1995. Comparison of four DNA-based methods for strain delineation of Candida lusitaniae. J. Clin. Microbiol. 33:1467-1470.
23. Kitch, T. T., M. R. Jacobs, M. R. McGinnis, and P. C. Appelbaum. 1996. Ability of RapID yeast system to identify 304 clinically significant yeasts within 5 hours. J. Clin. Microbiol. 34:1069-1071.
24. Komshian, S. V., A. Uwaydah, J. D. Sobel, and L. R. Crane. 1989. Fungemia caused by Candida species and Torulopsis in hospitalized patients. Frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 3:379-390.
25. Kubelik, A. R., and L. J. Szabo. 1995. High GC-primers are useful in RAPD analysis of fungi. Curr. Genet. 28:384-389.
26. Kullberg, B. J., and A. Voss. 1996. The changing pattern of Candida infections: different species and increased resistance. Ned. Tijdschr. Geneeskd. 140:148-151.
27. Land, G., J. Burke, C. Shelby, J. Rhodes, J. Collett, I. Bennett, and J. Johnson. 1996. Screening protocol for Torulopsis (Candida) glabrata. J. Clin. Microbiol. 34:2300-2303.
28. Lehmann, P. F., D. Lin, and B. A. Lasker. 1992. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J. Clin. Microbiol. 30:3249-3254.
29. Lin, D., and P. Lehmann. 1995. Random amplified polymorphic DNA for strain delineation within Candida tropicalis. J. Med. Vet. Mycol. 33:241-246.
30. Magee, B. B., E. H. A. Rikkerink, and P. T. Magee. 1988. Methods for the genetics and molecular biology of Candida albicans. Anal. Biochem. 175: 361-372.
31. Magee, B. B., T. M. D'Souza, and P. T. Magee. 1987. Strain and species identification by restriction fragment length polymorphisms in the ribosomal DNA repeat of Candida species. J. Bacteriol. 169:1639-1643.
32. Magee, P. T. 1993. Variations in chromosome size and organization in Candida albicans and Candida stellatoidea. Trends Microbiol. 1:338-342.
33. Maiwald, M., R. Kappe, and H. G. Sonntag. 1994. Rapid presumptive identification of medically relevant yeasts to the species level by polymerase chain reaction and restriction enzyme analysis. J. Med. Vet. Mycol. 32:115-122.
34. Marichal, P., J. Gorrens, M. C. Coene, L. Le Jeune, and H. Vanden Bossche. 1995. Origin of differences in susceptibility of Candida krusei to azole anti-fungal agents. Mycoses 38:111-117.
35. McCullough, M. J., B. C. Ross, B. D. Dwyer, and P. C. Reade. 1994. Genotype and phenotype of oral Candida albicans from patients infected with the human immunodeficiency virus. Microbiology 140:1195-1202.
36. Merz, W. G. 1980. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J. Clin. Microbiol. 20:1194-1195.
37. Merz, W. G., C. Connelly, and P. Hieter. 1988. Variation of electrophoretic karyotypes among clinical isolates of Candida albicans. J. Clin. Microbiol. 26:842-845.
38. Odds, F. C., and R. Bernaerts. 1994. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J. Clin. Microbiol. 32:1923-1929.
39. Penner, G. A., A. Bush, R. Wise, W. Kim, L. Domier, K. Kasha, A. Laroche, G. Scoles, S. J. Molnar, and G. Fedak. 1993. Reproducibility of random amplified polymorphic DNA (RAPD) analysis among laboratories. PCR Methods Appl. 2:341-345.
40. Pfaller, M. A., A. Houston, and S. Coffman. 1996. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, C. krusei, and Candida (Torulopsis) glabrata. J. Clin. Microbiol. 34:58-61.
41. Pfaller, M. A., J. Rhine-Chalberg, S. W. Redding, J. Smith, G. Farinacci, A. W. Fothergill, and M. G. Rinaldi. 1994. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J. Clin. Microbiol. 32: 59-64.
42. Powderly, W., G. Kobayashi, G. Herzig, and G. Medoff. 1988. Amphotericin B resistant yeast infection in severely immunocompromised patients. Am. J. Med. 84:826-832.
43. Redding, S., J. Smith, G. Farinacci, M. G. Rinaldi, A. Fothergill, J. Rhine-Chalberg, and M. A. Pfaller. 1994. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin. Infect. Dis. 18:240-242.
44. Rinaldi, M. G. 1989. Emerging opportunists, p. 65-76. In D. Drutz (ed.), Systemic fungal infections: diagnosis and treatment II. The W. B. Saunders Company, Philadelphia, Pa.
45. Robert, F., F. Lebreton, M. E. Bougnoux, A. Paugam, D. Wassermann, M. Schlotterer, C. Tourte-Schaefer, and J. Dupouy-Camet. 1995. Use of random amplified polymorphic DNA as a typing method for Candida albicans in epidemiological surveillance of a burn unit. J. Clin. Microbiol. 33:2366-2371.
46. Ruhnke, M., A. Eigler, I. Tennagen, B. Geiseler, E. Engelmann, and M. Trautmann. 1994. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J. Clin. Microbiol. 32:2092-2098.
47. Rustchenko-Bulgac, E. P., F. Sherman, and J. B. Hicks. 1990. Chromosomal rearrangements associated with morphological mutants provide a means for genetic variation of Candida albicans. J. Bacteriol. 172:1276-1283.
48. Sandhu, G. S., B. C. Kline, L. Stockman, and G. D. Roberts. 1995. Molecular probes for diagnosis of fungal infections. J. Clin. Microbiol. 33:2913-2919.
49. Scherer, S., and D. A. Stevens. 1987. Application of DNA typing methods to epidemiology and taxonomy of Candida species. J. Clin. Microbiol. 25:675-679.
50. Schonian, G., O. Meusel, H. J. Tietz, W. Meyer, Y. Graser, I. Tausch, W. Presber, and T. G. Mitchell. 1993. Identification of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses 36:171-179.
51. Spinillo, A., E. Capuzzo, T. O. Egbe, F. Baltaro, S. Nicola, and G. Piazzi. 1995. Torulopsis glabrata vaginitis. Obstet. Gynecol. 85:993-998.
52. 51a. Steffan, P., J. A. Vazquez, and R. A. Akins. Unpublished data.
53. Stevens, D. A., F. C. Odds, and S. Scherer. 1990. Application of DNA typing methods to Candida albicans epidemiology and correlations with phenotype. Rev. Infect. Dis. 12:258-266.
54. Sullivan, D., M. Henman, G. Moran, L. O'Neill, D. Bennett, D. Shanley, and D. Coleman. 1996. Molecular genetic approaches to identification, epidemiology and taxonomy of non-albicans Candida species. J. Med. Microbiol. 44:399-408.
55. Thanos, M., G. Schonian, W. Meyer, C. Schweynoch, Y. Graser, T. G. Mitchell, W. Presber, and H. J. Tietz. 1996. Rapid identification of Candida species by DNA fingerprinting with PCR. J. Clin. Microbiol. 34:615-621.
56. Tietz, H. J., A. Kussner, M. Thanos, M. P. de Andrade, W. Presber, and G. Schonian. 1995. Phenotypic and genotypic characterization of unusual vaginal isolates of Candida albicans from Africa. J. Clin. Microbiol. 33:2462-2465.
57. van Belkum, A., W. Melchers, B. E. de Pauw, S. Scherer, W. Quint, and J. F. Miles. 1994. PCR-mediated genotyping of Candida albicans strains from bone marrow transplant patients. Bone Marrow Transplant. 13:811-815.
58. Vazquez J. A., A. Beckley, S. Donabedian, J. D. Sobel, and M. J. Zervos. 1993. Comparison of restriction enzyme analysis versus pulse-field gradient electrophoresis as a typing system for Torulopsis and Candida species other than C. albicans. J. Clin. Microbiol. 31:2021-2030.
59. Vazquez, J. A., A. Beckley, J. D. Sobel, and M. J. Zervos. 1991. Comparison of restriction enzyme analysis versus pulsed-field gradient gel electrophoresis as a typing system for Candida albicans. J. Clin. Microbiol. 29:962-967.
60. Vazquez, J. A., T. Lundstrom, L. Dembry, P. Chandrasekar, D. Boikov, and M. B. Perri. 1995. Invasive Candida guilliermondii infection: in vitro susceptibility studies and molecular analysis. Bone Marrow Transplant. 16:849-853.
61. Weissman, A., I. Berdicevsky, and B. Cavari. 1995. Molecular identification of Candida albicans. J. Med. Vet. Mycol. 33:205-207.
62. Williams, A. G., A. R. Kubelik, K. J. Livak, J. A. Rafalski, and S. V. Tingey. 1990. DNA polymorphisms amplified by arbitrary primers are useful as genetic markers. Nucleic Acids Res. 18:6531-6535.
63. Williams, D. W., M. J. Wilson, M. A. O. Lewis, and A. J. C. Potts. 1995. Identification of Candida species by PCR and restriction fragment length polymorphism analysis of intergenic spacer regions of ribosomal DNA. J. Clin. Microbiol. 33:2476-2479.
64. Wingard, J. R. 1995. Importance of Candida species other than C. albicans as pathogens in oncology. Clin. Infect. Dis. 20:115-125.